A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical trial led by the Icahn School of Medicine at Mount Sinai.
Cytochromes P450 enzymes exhibit unique soft-robotic properties, study reveals
Study reveals an important discovery in the realm of nanomachines within living systems.
August 8, 2023